- €1.46bn
- €1.52bn
- €1.22bn
- 84
- 55
- 78
- 87
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 951 | 822 | 938 | 1,116 | 1,215 |
Cost of Revenue | |||||
Gross Profit | 276 | 231 | 280 | 311 | 321 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 827 | 766 | 816 | 974 | 1,078 |
Operating Profit | 124 | 56.1 | 121 | 142 | 137 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 115 | 47.4 | 108 | 143 | 119 |
Provision for Income Taxes | |||||
Net Income After Taxes | 80.9 | 30 | 73.8 | 104 | 103 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 80.6 | 31.4 | 73.4 | 103 | 102 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 80.6 | 31.4 | 73.4 | 103 | 102 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.83 | 3.17 | 3.32 | 4.54 | 4.59 |
Dividends per Share |